GO:1900079 regulation of arginine biosynthetic process: Metabolic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900079 describes any process that modulates the frequency, rate or extent of arginine biosynthetic process, a central node in nitrogen metabolism.
• Arginine biosynthesis is tightly regulated because arginine sits at the crossroads of nitrogen metabolism, connecting the urea cycle, polyamine synthesis, and nitric oxide production.
• In bacteria such as Escherichia coli, arginine biosynthesis is controlled by transcriptional attenuation, feedback inhibition, and global nitrogen regulators.
• Protein arginine methyltransferases (PRMTs) post-translationally modify arginine residues in proteins, indirectly influencing arginine availability and biosynthetic flux.
• Dysregulation of arginine biosynthetic pathways is implicated in cancer, immune dysfunction, and neurodegenerative conditions.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of regulatory nodes controlling arginine biosynthesis.
Description
The Gene Ontology term GO:1900079, regulation of arginine biosynthetic process, encompasses any process that modulates the frequency, rate or extent of arginine biosynthetic process. Arginine is a semi-essential amino acid that serves as a precursor for polyamines, nitric oxide, and creatine, and its biosynthesis is intimately linked to nitrogen metabolism. Because arginine availability influences cell growth, immune function, and disease progression, understanding how its biosynthesis is regulated is of broad biomedical importance. In prokaryotes such as Escherichia coli, arginine biosynthesis is controlled by a sophisticated network of transcriptional attenuation, feedback inhibition, and global nitrogen regulatory proteins. In eukaryotes, the pathway is compartmentalized and subject to additional layers of regulation, including post-translational modification of pathway enzymes and regulatory proteins by arginine methylation. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1900079, covering its definition, biological significance, key genes, disease links, and experimental strategies for investigation.
regulation of arginine biosynthetic process At A Glance
| GO ID | GO:1900079 |
|---|---|
| GO term | regulation of arginine biosynthetic process |
| Ontology | biological_process |
| Synonym | regulation of arginine anabolism; regulation of arginine biosynthesis; regulation of arginine formation; regulation of arginine synthesis |
| Major function | Modulates the frequency, rate or extent of arginine biosynthetic process |
| Related pathways | Nitrogen metabolism, urea cycle, polyamine biosynthesis, nitric oxide synthesis |
| Key regulators | ArgR, AhrC, NtrC, PRMTs, and pathway-specific enzymes |
| Disease relevance | Cancer, immune disorders, neurodegeneration, metabolic syndromes |
What Is GO:1900079?
According to the QuickGO definition, GO:1900079 (regulation of arginine biosynthetic process) refers to any process that modulates the frequency, rate or extent of arginine biosynthetic process. In other words, it includes all molecular events that control how much and how fast arginine is produced from precursor molecules. This regulation can occur at multiple levels, including transcription, translation, enzyme activity, and feedback inhibition, and it ensures that arginine levels are matched to cellular demands for protein synthesis, polyamine production, and nitrogen homeostasis.
Why Is regulation of arginine biosynthetic process Important in Cell Biology?
Regulation of arginine biosynthesis is critical because arginine is not only a proteinogenic amino acid but also a precursor for polyamines, nitric oxide, and creatine, and it plays a central role in nitrogen disposal and immune function. Dysregulation of this process can lead to altered polyamine levels that promote ferroptosis in cancer cells, or to immune dysfunction due to insufficient arginine availability for T-cell proliferation. Moreover, arginine methylation of proteins by PRMTs can affect RNA splicing and cell growth, indirectly influencing arginine biosynthetic flux. Therefore, understanding GO:1900079 is essential for developing therapeutic strategies targeting metabolic vulnerabilities in cancer and other diseases.
• Arginine is a semi-essential amino acid required for protein synthesis, polyamine production, and nitric oxide generation.
• Regulation of arginine biosynthesis ensures nitrogen balance and prevents toxic accumulation of intermediates.
• In cancer, polyamine-mediated ferroptosis amplification can be targeted by modulating arginine metabolism.
• Arginine availability critically affects immune cell function, including T-cell activation and macrophage polarization.
• PRMT-mediated arginine methylation regulates RNA splicing and cell growth, linking arginine metabolism to gene expression.
• Bacterial arginine biosynthesis is a model system for understanding gene regulation and feedback inhibition.
• Dysregulated arginine biosynthesis contributes to neurodegenerative diseases through altered protein arginine methylation.
• Plant arginine methylation regulates AGO2 function, highlighting evolutionary conservation of these regulatory mechanisms.
• Targeting arginine biosynthetic pathways offers therapeutic opportunities in metabolic disorders and cancer.
• CRISPR screens can identify novel regulators of arginine biosynthesis, accelerating drug target discovery.
What Happens During regulation of arginine biosynthetic process?
Transcriptional control of arginine biosynthetic genes
In simple terms: The cell decides how much arginine to make by turning the relevant genes on or off.
In Escherichia coli, the arginine biosynthetic genes are organized in operons and are transcriptionally regulated by the repressor ArgR and the activator AhrC in response to arginine availability. When arginine is abundant, ArgR binds to operator sites and inhibits transcription, while AhrC activates transcription under arginine-limiting conditions. This transcriptional control ensures that the cell does not waste energy synthesizing arginine when it is already available. In eukaryotes, transcriptional regulation of arginine biosynthetic genes is less understood but involves nutrient-sensing pathways and stress responses.
Feedback inhibition of enzyme activity
In simple terms: The end product, arginine, can directly block the first enzyme in the pathway to prevent overproduction.
The first committed step of arginine biosynthesis, catalyzed by N-acetylglutamate synthase (ArgA in E. coli), is feedback-inhibited by arginine. This allosteric regulation provides immediate control over pathway flux independent of transcription. In plants and fungi, similar feedback inhibition mechanisms exist, often involving the enzyme N-acetylglutamate kinase. Such feedback loops are critical for maintaining arginine homeostasis and preventing wasteful consumption of ATP and glutamate.
Global nitrogen regulation
In simple terms: The cell integrates information about overall nitrogen status to adjust arginine production.
In bacteria, the global nitrogen regulator NtrC controls the expression of many nitrogen assimilation genes, including those involved in arginine biosynthesis, in response to nitrogen limitation. This ensures that arginine synthesis is coordinated with the availability of nitrogen sources. In eukaryotes, the target of rapamycin (mTOR) pathway senses amino acid levels, including arginine, and regulates cell growth and metabolism accordingly. Thus, arginine biosynthesis is embedded in a larger regulatory network that monitors cellular nutrient status.
Post-translational modification of pathway enzymes
In simple terms: Enzymes in the pathway can be chemically modified to change their activity.
Protein arginine methyltransferases (PRMTs) catalyze the methylation of arginine residues in various proteins, including metabolic enzymes, thereby modulating their activity and interactions. For example, PRMT-mediated methylation of hnRNPA1 affects RNA splicing and cell growth, which can indirectly influence the expression of arginine biosynthetic genes. Additionally, arginine methylation of FUS regulates its phase separation, linking arginine metabolism to neurodegenerative disease mechanisms. These post-translational modifications add another layer of regulation to arginine biosynthesis.
Key Genes Involved in GO:1900079 regulation of arginine biosynthetic process
The following genes and proteins are key players in the regulation of arginine biosynthetic process across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ArgR | Transcriptional repressor of arginine biosynthetic operons in E. coli | Model for feedback repression and gene regulation |
| AhrC | Transcriptional activator of arginine biosynthetic genes in E. coli | Studying activator-repressor interplay |
| NtrC | Global nitrogen regulator controlling arginine biosynthesis under nitrogen limitation | Linking nitrogen status to arginine production |
| ArgA | N-acetylglutamate synthase, first enzyme of arginine biosynthesis | Feedback inhibition by arginine |
| ArgB | N-acetylglutamate kinase, second enzyme | Allosteric regulation and pathway flux |
| ArgC | N-acetylglutamate semialdehyde dehydrogenase | Redox balance and pathway intermediates |
| ArgD | Acetylornithine aminotransferase | Amino group transfer in arginine synthesis |
| ArgE | Acetylornithine deacetylase | Ornithine production |
| ArgF/ArgI | Ornithine transcarbamylase | Channeling ornithine into arginine synthesis |
| ArgG | Argininosuccinate synthase | Rate-limiting step in arginine synthesis |
| ArgH | Argininosuccinate lyase | Final step of arginine biosynthesis |
| PRMT1 | Protein arginine methyltransferase 1 | Methylation of proteins affecting RNA splicing and growth |
| PRMT5 | Protein arginine methyltransferase 5 | Symmetric dimethylation of arginine residues |
| hnRNPA1 | RNA-binding protein methylated by PRMTs | Regulation of RNA splicing and cell growth |
| FUS | RNA-binding protein with arginine methylation | Phase separation and neurodegeneration |
| AGO2 | Argonaute protein regulated by arginine methylation in plants | Small RNA pathways and gene silencing |
How Is regulation of arginine biosynthetic process Regulated?
Regulation of arginine biosynthetic process is achieved through multiple mechanisms. In bacteria, the ArgR repressor and AhrC activator respond to arginine levels, while NtrC integrates nitrogen status. Feedback inhibition of the first enzyme, ArgA, by arginine provides immediate control. In eukaryotes, mTOR signaling senses amino acid availability and regulates cell growth, indirectly influencing arginine biosynthesis. Additionally, PRMT-mediated arginine methylation of proteins such as hnRNPA1 and FUS can affect RNA processing and phase separation, adding layers of post-transcriptional and post-translational regulation. These regulatory circuits ensure that arginine production is matched to cellular demands for protein synthesis, polyamines, and nitric oxide.
regulation of arginine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRMT1 | Cancer, RNA splicing dysregulation | Knockout cell lines, point mutants |
| FUS | ALS, frontotemporal dementia | Knock-in of methylation-deficient mutants |
| hnRNPA1 | Cancer, splicing-related growth defects | Overexpression and knockout models |
| AGO2 | Plant development, small RNA pathways | Point mutation of methylation sites |
| ArgR | Bacterial pathogenesis, metabolic regulation | Knockout in E. coli |
Cancer metabolism and ferroptosis
Arginine biosynthesis supports rapid cancer cell proliferation by providing precursors for polyamines and nucleotides. Polyamine-mediated ferroptosis amplification has been identified as a targetable vulnerability in cancer, where dysregulated arginine metabolism contributes to oxidative stress and cell death. Targeting the regulation of arginine biosynthesis may therefore offer therapeutic strategies for selective cancer cell killing.
Immune function and inflammation
Arginine is critical for immune cell function, including T-cell proliferation and macrophage activity. Regulation of arginine biosynthesis affects the availability of arginine for nitric oxide production, which is important for immune defense and inflammation. Dysregulation can lead to immune suppression in tumor microenvironments, where arginine depletion impairs anti-tumor immunity.
Neurodegeneration and protein aggregation
Arginine methylation of RNA-binding proteins such as FUS modulates their phase separation and aggregation, processes implicated in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Dysregulation of arginine biosynthetic pathways may therefore contribute to neurodegenerative disease by altering the methylation status of key proteins. Additionally, PRMT-mediated methylation of hnRNPA1 affects RNA splicing, which can impact neuronal function.
From regulation of arginine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ArgR affect arginine biosynthesis flux? | ArgR knockout E. coli strain |
| How does PRMT1 methylation of hnRNPA1 impact splicing? | PRMT1 knockout or point-mutant cell lines |
| What is the effect of FUS arginine methylation on phase separation? | FUS knock-in with methylation-deficient mutations |
| Can overexpression of ArgG increase arginine production? | ArgG overexpression in bacterial or mammalian cells |
| Which genes regulate arginine biosynthesis under nitrogen limitation? | CRISPR library screening in E. coli or mammalian cells |
| Does AGO2 methylation affect small RNA loading? | AGO2 point mutants in Arabidopsis |
How to Study the regulation of arginine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify transcriptional regulators of arginine biosynthesis |
| Methylproteomics | Arginine methylation sites | Map PRMT substrates and their functions |
| Metabolic flux analysis | Pathway flux and intermediate levels | Quantify arginine production and feedback inhibition |
| CRISPR knockout screening | Gene essentiality and fitness | Discover novel regulators of arginine biosynthesis |
| Western blot | Protein expression and modification | Validate PRMT-mediated methylation of target proteins |
| Immunofluorescence | Protein localization and phase separation | Study FUS aggregation and methylation effects |
| Bacterial growth assays | Arginine prototrophy | Test ArgR and AhrC mutants in E. coli |
Transcriptomics and RNA-seq
RNA sequencing can quantify expression changes in arginine biosynthetic genes under different conditions, such as nitrogen limitation or arginine supplementation. This method helps identify transcriptional regulators and their targets. In eukaryotes, RNA-seq can reveal splicing changes mediated by PRMTs that indirectly affect arginine metabolism.
Proteomics and methylproteomics
Mass spectrometry-based proteomics can detect post-translational modifications, including arginine methylation, on pathway enzymes and regulatory proteins. Profiling the PRMT methylome reveals substrates such as hnRNPA1 and their roles in RNA splicing and cell growth. This approach is essential for understanding how arginine methylation regulates biosynthetic flux.
Metabolic flux analysis
Stable isotope tracing and metabolomics can measure flux through the arginine biosynthetic pathway, identifying rate-limiting steps and feedback inhibition. By feeding labeled precursors such as 15N-glutamate, researchers can quantify arginine production and its regulation in real time.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify novel regulators of arginine biosynthesis. Libraries targeting metabolic enzymes, transcription factors, and PRMTs can reveal genes that modulate arginine levels and cell fitness under stress conditions.
How CRISPR Can Be Used to Study GO:1900079 regulation of arginine biosynthetic process
Knockout
CRISPR knockout of genes such as ArgR, AhrC, or PRMTs can reveal their roles in regulating arginine biosynthesis. For example, ArgR knockout in E. coli leads to constitutive expression of arginine biosynthetic genes, increasing pathway flux. In mammalian cells, PRMT1 knockout alters arginine methylation patterns and affects RNA splicing and cell growth.
Point Mutation
Introducing point mutations in key regulatory sites, such as the arginine-binding pocket of ArgA or methylation sites in hnRNPA1, allows precise dissection of feedback inhibition and post-translational regulation. For instance, mutation of the arginine sensor in ArgA can abolish feedback inhibition, leading to overproduction of arginine.
Knock-in
Knock-in of tagged or mutant versions of genes, such as FUS with methylation-deficient arginine residues, enables studies of phase separation and neurodegeneration. Similarly, knock-in of fluorescent tags on pathway enzymes allows real-time imaging of their localization and dynamics.
Overexpression
Overexpression of rate-limiting enzymes like ArgG or ArgH can increase arginine production and reveal bottlenecks in the pathway. In cancer research, overexpression of PRMTs can mimic pathological states and help identify therapeutic vulnerabilities.
How EDITGENE Supports regulation of arginine biosynthetic process Research
Researchers studying regulation of arginine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway control or is merely correlated with metabolic changes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of arginine biosynthetic process research.
Frequently Asked Questions About regulation of arginine biosynthetic process
What is GO:1900079?
GO:1900079 is the Gene Ontology term for regulation of arginine biosynthetic process, defined as any process that modulates the frequency, rate or extent of arginine biosynthetic process.
What genes are involved in regulation of arginine biosynthetic process?
Key genes include ArgR, AhrC, NtrC, ArgA, ArgB, ArgC, ArgD, ArgE, ArgF, ArgG, ArgH in bacteria, and PRMTs, hnRNPA1, FUS, and AGO2 in eukaryotes.
How is arginine biosynthesis regulated in E. coli?
In E. coli, arginine biosynthesis is regulated by the repressor ArgR, activator AhrC, global nitrogen regulator NtrC, and feedback inhibition of ArgA by arginine.
Why is arginine biosynthesis important for cancer?
Arginine biosynthesis supports cancer cell proliferation and polyamine production; its dysregulation can lead to ferroptosis, making it a targetable vulnerability.
What role does arginine methylation play in gene regulation?
Arginine methylation by PRMTs modifies proteins like hnRNPA1 and FUS, affecting RNA splicing, phase separation, and cell growth.
Can CRISPR be used to study arginine biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of regulatory genes in arginine biosynthesis.
What diseases are linked to arginine biosynthetic process?
Diseases include cancer, immune dysfunction, and neurodegenerative disorders such as ALS, linked to dysregulated arginine metabolism and protein methylation.
What methods are used to study regulation of arginine biosynthesis?
Methods include RNA-seq, methylproteomics, metabolic flux analysis, CRISPR screening, and Western blotting.
How does nitrogen availability affect arginine biosynthesis?
Global nitrogen regulators like NtrC in bacteria and mTOR in eukaryotes sense nitrogen status and adjust arginine biosynthesis accordingly.
What are the synonyms for GO:1900079?
Synonyms include regulation of arginine anabolism, regulation of arginine biosynthesis, regulation of arginine formation, and regulation of arginine synthesis.
Conclusion
GO:1900079, regulation of arginine biosynthetic process, represents a critical control point in nitrogen metabolism with far-reaching implications for cell growth, immune function, and disease. The integration of transcriptional, post-translational, and feedback regulatory mechanisms ensures that arginine production meets cellular demands while avoiding toxicity. Dysregulation of this process contributes to cancer, immune disorders, and neurodegeneration, making it an attractive target for therapeutic intervention. Advances in CRISPR-based models and multi-omics technologies are poised to accelerate the discovery of novel regulatory nodes and drug targets within this pathway.
References
- 1. Fung TS et al.. 2025. Arginine: at the crossroads of nitrogen metabolism.. EMBO J 44(5):1275-1293 PMID: 39920310
- 2. Bi G et al.. 2024. Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.. Nat Commun 15(1):2461 PMID: 38504107
- 3. Li WJ et al.. 2021. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.. Nat Commun 12(1):1946 PMID: 33782401
- 4. Qamar S et al.. 2018. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.. Cell 173(3):720-734.e15 PMID: 29677515
- 5. Charlier D et al.. 2019. Regulation of arginine biosynthesis, catabolism and transport in Escherichia coli.. Amino Acids 51(8):1103-1127 PMID: 31267155
- 6. Popovic PJ et al.. 2007. Arginine and immunity.. J Nutr 137(6 Suppl 2):1681S-1686S PMID: 17513447
- 7. Morales Y et al.. 2016. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).. Arch Biochem Biophys 590:138-152 PMID: 26612103
- 8. Hu P et al.. 2019. Dual regulation of Arabidopsis AGO2 by arginine methylation.. Nat Commun 10(1):844 PMID: 30783097
